Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | October 06, 2022 08:18am

Gainers

  • Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.
  • Revelation Biosciences (NASDAQ:REVB) shares moved upwards by 34.12% to $0.34. The market value of their outstanding shares is at $7.9 million.
  • Revelation Biosciences (NASDAQ:REVBU) stock rose 27.77% to $0.46.
  • Spruce Biosciences (NASDAQ:SPRB) stock moved upwards by 18.65% to $1.59. The company's market cap stands at $37.4 million.
  • Annovis Bio (NYSE:ANVS) shares moved upwards by 13.68% to $15.2. The company's market cap stands at $124.0 million.
  • Provention Bio (NASDAQ:PRVB) shares moved upwards by 13.33% to $5.61. The company's market cap stands at $457.4 million.

Losers

  • Heart Test Laboratories (NASDAQ:HSCS) shares fell 12.0% to $1.32 during Thursday's pre-market session. The market value of their outstanding shares is at $10.8 million.
  • Hyperfine (NASDAQ:HYPR) shares decreased by 11.71% to $1.07. The market value of their outstanding shares is at $75.2 million.
  • Applied Therapeutics (NASDAQ:APLT) stock fell 9.37% to $0.86. The market value of their outstanding shares is at $41.3 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares declined by 8.98% to $7.71. The market value of their outstanding shares is at $11.3 million.
  • Calithera Biosciences (NASDAQ:CALA) shares fell 6.06% to $2.95. The market value of their outstanding shares is at $14.3 million.
  • Axcella Health (NASDAQ:AXLA) shares fell 5.44% to $1.74. The company's market cap stands at $91.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANVS APLT ATXI AXLA CALA HSCS HYPR PRVB REVB REVBU SPRB STAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist